Trials / Conditions / Bronchiolitis Obliterans Syndrome (BOS)
Bronchiolitis Obliterans Syndrome (BOS)
5 registered clinical trials studyying Bronchiolitis Obliterans Syndrome (BOS) — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Enrolling By Invitation | Mechanisms and Targeted Therapy of Airway Basal Cell Dysfunction in Bronchiolitis Obliterans Syndrome NCT07018804 | Haikou Affiliated Hospital of Central South University Xiangya School of Medicine | N/A |
| Completed | ex Vivo Study of Liposomes Loaded With Everolimus in Chronic Lung Allograft Disfunction NCT07234760 | Fondazione IRCCS Policlinico San Matteo di Pavia | — |
| Terminated | A Safety Study of Liposomal Cyclosporine A to Treat Bronchiolitis After Hematopoietic Transplant (BOSTON-4) NCT04107675 | Zambon SpA | Phase 2 |
| Recruiting | Nintedanib in Patients With Bronchiolitis Obliterans Syndrome Following Hematopoietic Stem Cell Transplantatio NCT03805477 | University Hospital, Basel, Switzerland | Phase 2 |
| Active Not Recruiting | Extracorporeal Photopheresis for Medicare Recipients of Lung Allografts NCT02181257 | Washington University School of Medicine | Phase 3 |